Among the members of the CHU de Québec-Université Laval Research Centre, an abstract may be submitted by:

  • Graduate students
  • MD student registered in research program
  • Postdoctoral and MD fellows
  • Research employees (person involved in carrying out a fundamental or clinical research project, project coordinators or staff operating a scientific platform)
  • Researchers (if no student in your lab is able to submit and present the work)

Abstracts

  • Each person may submit only one abstract.
  • Abstracts must be submitted online no later than Sunday, April 3, 2022 at 11:30 p.m.
  • Several categories of submissions, described below, are available, depending on the type of presentation desired. If you are submitting for an oral presentation but are not selected, we will offer you another mode of presentation according to the choices you have selected. If you did not mention any other type of presentation when you submitted, you will be able to submit a virtual poster only.
  • See the evaluation criteria.
  • In your submission form, please select, among the 11 themes described below, the one that is most appropriate for the work presented. The choice of this theme is important because it determines your presentation session. The adequacy of the choice of the theme will be part of the evaluation criteria of your abstract.
  • The abstract can be written in French or English.
  • It should be limited to 350 words and include the following sections: ntroduction (context, objectives or problem), method (experiments or protocol put in place), results (preliminary, final or expected), conclusions (interpreted or expected).

The presentation of services and technologies is reserved for platforms.

  • All abstracts will be evaluated by a scientific committee. A maximum of 64 oral presentations, 64 mini-presentations and 100 poster presentations will be selected. Presenters will be notified in early May.
  • All accepted abstracts will be published on the JDLR2022 website

Type of sybmissions/presentation and instructions

You can submit your abstract in 4 categories:

  • Oral presentation
  • Mini-oral presentation
  • Poster presentation
  • Virtual poster

The 3 first type of submission mean an in-person presentation (oral or poster). These presentations will be automatically evaluated and you will then be eligible to receive a presentation prize according to your status. See the evaluation criteria.

All presentations and posters may be in English or French. The language used must be scientific and accessible to a diverse and interdisciplinary audience.

All accepted abstracts and their associated documents will be published on the JDLR2022 website for consultation by all registered participants as of May 23, 2022.

You can use the CRCHU graphic design service to produce your presentation document. Please pay attention to the addition and proper use of the official logos of the CRCHU, the axes or your granting agencies.

Oral presentation (x 64 in 8 thematic sessions and 2 specific session of 4)

They will take place in rooms and will be broadcast simultaneously on Zoom.

Duration: 10 minutes and 2-3 minutes of questions

Visual support: Powerpoint slideshow, in French or English. No limit on the number of slides. Maximum file size: 5 MB.

You will have the choice whether or not to add your slideshow to your abstract in your submission form so that it can be viewed by registered participants . See how to access ma submission to upload my presentation documents

Mini-oral presentation (x 64 in 8 sessions)

They will take place in rooms and will be broadcast simultaneously on Zoom.

Duration: 3 minutes with 1-2 minutes of questions

Visual support: A poster in image format ( .jpg, .jpeg, .png, .gif, landscape orientation preferred, 2 MB maximum) or a Powerpoint slideshow of 2 slides maximum.

Upon confirmation of your presentation type, you will need to upload your Powerpoint slideshow or poster to your submission form no later than Sunday, May 22, 11:30 a.m. See how to access my submission to upload my presentation documents.

If you make a mini-oral presentation of a poster, you will not have to print it. You will have no further presentation to make. Only your oral mini-presentation, in the room, will be evaluated.

Poster presentation (x 100, 50 per day)

A 45-minute poster presentation session will be assigned to you on May 25 or 26, during which you will have to present your poster in front of 2 evaluators and visitors who request it.

Paper poster size: horizontal, maximum dimensions of 3ft x 5ft

Duration: 2-3 minutes and 2-3 minutes of questions

In addition to your paper poster, you will be able to upload your poster to your submission form to make it accessible to all registered participants as of May 23. See how to access ma submission to upload my presentation documents

Virtual poster only

As the number of oral presentations, mini-presentations and face-to-face posters is limited, some abstracts will be selected to submit a digital poster only. The poster will be available to registered participants as of May 23, 2022 on the JDLR2022 website who will be able to contact you by email. You will not have to present your poster. This type of submission is not eligible for a presentation prize.

Poster format: Picture .jpg, .jpeg, .png, .gif (landscape orientation preferred, 2 MB maximum)

After confirming your presentation type, you will need to upload your poster to your submission form no later than Sunday, May 22, 11:30 a.m. See how to access my submission to upload my presentation documents.

Table of presentation types and prize eligibility according to your status

Table of presentation types and prize eligibility according to your status

Submission themes

  1. Clinical and translational research. Any study involving cohorts of patients or aiming to produce concrete clinical applications based on fundamental knowledge.
  2. Imaging techniques. Any project using imaging data for the analysis of cells, tissues or animals or any project allowing the development or improvement of imaging techniques.
  3. Genetic engineering and functional genomics. Any project studying the function of genes, their transcriptional regulation or genomic instability or developing new genome editing strategies by CRISPR-CAS9 in particular.
  4. Cell communication and signaling. Any study aimed at elucidating intracellular signaling pathways or communication mechanisms involved in various cellular and molecular functions or processes.
  5. Use and development of animal models. Any project using animal models of human diseases or behavioural studies. The benefits and limitations of the model in question could be shared.
  6. Tissue engineering and biomaterials. Any project aimed at the development of three-dimensional cell culture models or organoids, the development or use of biomaterials.
  7. Immunology and micro-organisms. Any project related to the study of microorganisms or immunology, in any field, including but not limited to: cancer, neurology, metabolic conditions, infectious, inflammatory or autoimmune diseases, degenerative diseases, reproductive system, musculoskeletal system.
  8. "Omics" approaches and bioinformatics. Any project describing genomics, proteomics, lipidomics, metabolomics, etc. data or developing biostatistics, bioinformatics, big data and artificial intelligence strategies and analyses.
  9. Public Health and Social Services. Any project involving population or epidemiological data in the field of health or social services. Project addressing sustainable health.
  10. Study and development of drugs. Any research project involving aspects of drug development, whether at the level of synthesis (chemistry), development (molecular targets), or deployment (clinical phases).
  11. Scientific platform. Any description of service, equipment or technology offered to the community by a scientific platform.
Powered by